Boston Scientific (BSX) Construction in Progress (2009 - 2026)
Boston Scientific (BSX) posted quarterly Construction in Progress of $911.0 million for Q2 2026, down 12.49% year-over-year from $1.0 billion in Q2 2025, and down 18.3% on a QoQ basis from $1.1 billion in Q1 2026.
Boston Scientific (BSX) Construction in Progress (2009 - 2026) Analysis & Trends
Boston Scientific has reported Construction in Progress for 18 years, with the latest figure at $911.0 million in Q2 2026.
- Construction in Progress for Q2 2026 came in at $911.0 million, down 12.49% year-over-year; the trailing twelve-month figure through Jun 2026 was $911.0 million (down 12.49% YoY), and the FY2025 annual result was $1.2 billion, up 12.17% from the prior year.
- Construction in Progress eased to $911.0 million in Q2 2026, from $1.1 billion in the prior quarter.
- Over five years, Construction in Progress peaked at $1.2 billion in Q4 2025 and troughed at $513.0 million in Q3 2022.
- A 5-year average of $825.4 million and a median of $888.5 million in 2024 frame the typical range for Construction in Progress.
- The widest annual swing landed in 2024, when Construction in Progress surged 55.2%; it then dropped 12.49% in 2026.
- A 5-year view of Construction in Progress shows it stood at $598.0 million in 2022, then surged by 43.31% to $857.0 million in 2023, then gained by 20.77% to $1.0 billion in 2024, then grew by 12.17% to $1.2 billion in 2025, then declined by 21.53% to $911.0 million in 2026.
- Per Business Quant data, the three most recent Construction in Progress figures were $911.0 million in Q2 2026, $1.1 billion in Q1 2026, and $1.2 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | - |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 911.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | - |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 455.10 Mn |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 911.00 Mn |
| Mar 31, 2026 | 1.12 Bn |
| Dec 31, 2025 | 1.16 Bn |
| Sep 30, 2025 | 936.00 Mn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 1.04 Bn |
| Sep 30, 2024 | 966.00 Mn |
| Jun 30, 2024 | 897.00 Mn |
| Mar 31, 2024 | 880.00 Mn |
| Dec 31, 2023 | 857.00 Mn |
| Sep 30, 2023 | 691.00 Mn |
| Jun 30, 2023 | 604.00 Mn |
| Mar 31, 2023 | 567.00 Mn |
| Dec 31, 2022 | 598.00 Mn |
| Sep 30, 2022 | 513.00 Mn |
| Jun 30, 2022 | 537.00 Mn |
| Mar 31, 2022 | 539.00 Mn |
| Dec 31, 2021 | 605.00 Mn |
| Sep 30, 2021 | 465.00 Mn |